BioSpace News Archive

Metastatic biomarker Cyr61 found by researchers in 40% of breast cancer CTCs may be a novel therapeutic target in treating drug-resistant breast cancers

People who are affected by severe pain from arthritis can undergo two options of treatment: ankle fusion and ankle replacement

Disposable products are primarily made from plastic, paper, polystyrene foam, or cotton.

Muscle relaxation drugs are a group of medicines used to reduce and relax tension in muscles during spasms, hyperreflexia, and muscle pain.

Nordic Nanovector ASA provides an update on PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® in 3rd-line relapsed/refractory follicular lymphoma.

Retina is a layer of nerve tissue lining the back of the eye. It receives light and converts it into neural signals and sends these signals to the brain for visual recognition.

Dental implants manufactured from titanium are known to be compatible with body tissues and are able to bond with adjacent bone during healing.

On November 8, 2020, we announced positive topline readout of Part A of our Phase 3 pivotal trial, NefIgArd. The results were statistically significant and clinically relevant: proteinuria showed a 31% reduction versus baseline, a stronger effect than what was seen in the Phase 2b, which is generally not expected when moving from Phase 2 to Phase 3.

Targovax ASA, a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, will host a virtual Capital Markets Day for investors, analysts and journalists

Nordic Nanovector ASA announces its results for the fourth quarter and full year 2020. A live webcast presentation by Nordic Nanovector’s management team will take place at 08.30 CET.